Search Results
Search for other papers by A Edlund in
Google Scholar
PubMed
Search for other papers by M Barghouth in
Google Scholar
PubMed
Search for other papers by M Hühn in
Google Scholar
PubMed
Search for other papers by M Abels in
Google Scholar
PubMed
Search for other papers by J S E Esguerra in
Google Scholar
PubMed
Search for other papers by I G Mollet in
Google Scholar
PubMed
Search for other papers by E Svedin in
Google Scholar
PubMed
Search for other papers by A Wendt in
Google Scholar
PubMed
Search for other papers by E Renström in
Google Scholar
PubMed
Search for other papers by E Zhang in
Google Scholar
PubMed
Search for other papers by N Wierup in
Google Scholar
PubMed
Pediatric Pulmonology, Erasmus MC, Rotterdam, the Netherlands
Search for other papers by B J Scholte in
Google Scholar
PubMed
Search for other papers by M Flodström-Tullberg in
Google Scholar
PubMed
Search for other papers by L Eliasson in
Google Scholar
PubMed
F508del beta cells have defective exocytosis and insulin secretion. Finally, we measured islet glucagon and somatostatin secretion. The data presented highlight the important contribution of CFTR in beta cells for functional insulin secretion
Search for other papers by Glyn M Noguchi in
Google Scholar
PubMed
Search for other papers by Vincent C Castillo in
Google Scholar
PubMed
Search for other papers by Cynthia J Donaldson in
Google Scholar
PubMed
Search for other papers by Marcus R Flisher in
Google Scholar
PubMed
Search for other papers by Ariana T Momen in
Google Scholar
PubMed
Search for other papers by Alan Saghatelian in
Google Scholar
PubMed
Department of Physiology & Membrane Biology, University of California Davis, Davis, California, USA
Search for other papers by Mark O Huising in
Google Scholar
PubMed
Introduction The alpha cells of the pancreatic islets of Langerhans are important physiological regulators of blood glucose that act to raise blood glucose levels via the actions of their principal hormone, glucagon. Despite being
Search for other papers by Elliott P Brooks in
Google Scholar
PubMed
Search for other papers by Lori Sussel in
Google Scholar
PubMed
Introduction α cells are one of four major endocrine cell types that reside in adult pancreatic endocrine clusters called the Islets of Langerhans. The islet α cells secrete the hormone glucagon in response to hypoglycemic conditions to
Search for other papers by Sarah L Armour in
Google Scholar
PubMed
Search for other papers by Jade E Stanley in
Google Scholar
PubMed
Search for other papers by James Cantley in
Google Scholar
PubMed
Division of Diabetes, Endocrinology, & Metabolism, Vanderbilt University Medical Center School of Medicine, Nashville, Tennessee, USA
Search for other papers by E Danielle Dean in
Google Scholar
PubMed
Search for other papers by Jakob G Knudsen in
Google Scholar
PubMed
Introduction Glucagon is secreted from alpha cells located in pancreatic islets of Langerhans and is an important counter-regulatory hormone to insulin, acting to increase blood glucose. Indeed, it was this physiological hyperglycaemic effect
Search for other papers by Paul Millar in
Google Scholar
PubMed
Search for other papers by Nupur Pathak in
Google Scholar
PubMed
Search for other papers by Vadivel Parthsarathy in
Google Scholar
PubMed
Search for other papers by Anthony J Bjourson in
Google Scholar
PubMed
Clinical Chemistry Laboratory, Western Health and Social Care Trust, Altnagelvin Hospital, Northern Ireland, UK
Search for other papers by Maurice O’Kane in
Google Scholar
PubMed
Search for other papers by Varun Pathak in
Google Scholar
PubMed
Search for other papers by R Charlotte Moffett in
Google Scholar
PubMed
Search for other papers by Peter R Flatt in
Google Scholar
PubMed
Search for other papers by Victor A Gault in
Google Scholar
PubMed
surge in the number of new drug classes such as glucagon-like peptide-1 (GLP-1) agonists, dipeptidylpeptidase-4 (DPP4) inhibitors and sodium glucose cotransporter-2 (SGLT2) inhibitors ( Bailey et al . 2016 ). Although these agents may be used as
Search for other papers by Rebecca McGirr in
Google Scholar
PubMed
Search for other papers by Leonardo Guizzetti in
Google Scholar
PubMed
Metabolism and Diabetes and Imaging Programs, Departments of Medical Biophysics, Pathology, Medicine, Lawson Health Research Institute, 268 Grosvenor Street, London, Ontario, Canada N6A 4V2
Metabolism and Diabetes and Imaging Programs, Departments of Medical Biophysics, Pathology, Medicine, Lawson Health Research Institute, 268 Grosvenor Street, London, Ontario, Canada N6A 4V2
Metabolism and Diabetes and Imaging Programs, Departments of Medical Biophysics, Pathology, Medicine, Lawson Health Research Institute, 268 Grosvenor Street, London, Ontario, Canada N6A 4V2
Search for other papers by Savita Dhanvantari in
Google Scholar
PubMed
Introduction Proglucagon is a prohormone that is expressed in the alpha cells of the pancreas, the L cells of the intestine and in select neurons of the brainstem. In the pancreatic alpha cell, PC2 cleaves proglucagon to yield glucagon ( Rouille et
Search for other papers by Maaike M Roefs in
Google Scholar
PubMed
Search for other papers by Françoise Carlotti in
Google Scholar
PubMed
Search for other papers by Katherine Jones in
Google Scholar
PubMed
Search for other papers by Hannah Wills in
Google Scholar
PubMed
Search for other papers by Alexander Hamilton in
Google Scholar
PubMed
Search for other papers by Michael Verschoor in
Google Scholar
PubMed
Search for other papers by Joanna M Williams Durkin in
Google Scholar
PubMed
Search for other papers by Laura Garcia-Perez in
Google Scholar
PubMed
Search for other papers by Melissa F Brereton in
Google Scholar
PubMed
Search for other papers by Laura McCulloch in
Google Scholar
PubMed
Search for other papers by Marten A Engelse in
Google Scholar
PubMed
Nuffield Department of Surgical Sciences, John Radcliffe Hospital, Oxford, UK
Search for other papers by Paul R V Johnson in
Google Scholar
PubMed
Search for other papers by Barbara C Hansen in
Google Scholar
PubMed
Search for other papers by Kevin Docherty in
Google Scholar
PubMed
Hubrecht Institute, Utrecht, the Netherlands
Search for other papers by Eelco J P de Koning in
Google Scholar
PubMed
Search for other papers by Anne Clark in
Google Scholar
PubMed
not identical methodologies. Tissue sections were rehydrated, and antigen retrieval was performed by heating slides in 0.01 M citrate buffer (pH = 6.0). Primary antibodies against insulin, glucagon, vimentin, Nkx6.1, Pdx1, N-cadherin, smooth muscle
Search for other papers by Affiong Ika Oqua in
Google Scholar
PubMed
Search for other papers by Yusman Manchanda in
Google Scholar
PubMed
Search for other papers by Emma Rose McGlone in
Google Scholar
PubMed
Search for other papers by Ben Jones in
Google Scholar
PubMed
Search for other papers by Sarah Rouse in
Google Scholar
PubMed
Search for other papers by Alejandra Tomas in
Google Scholar
PubMed
, characterised by Creutzfeldt in 1979, are peptide hormones secreted in the gastrointestinal tract in response to nutrients that potentiate the glucose-dependent secretion of insulin. The primary incretins include glucagon-like peptide 1 (GLP-1), secreted mainly
Departments of Biochemistry, Obstetrics and Gynecology and Women's Health, Medicine, Department of Pediatrics, Albert Einstein College of Medicine, 1300 Morris Park Avenue, F312, Bronx, New York 10461, USA
Departments of Biochemistry, Obstetrics and Gynecology and Women's Health, Medicine, Department of Pediatrics, Albert Einstein College of Medicine, 1300 Morris Park Avenue, F312, Bronx, New York 10461, USA
Search for other papers by Maureen J Charron in
Google Scholar
PubMed
Search for other papers by Patricia M Vuguin in
Google Scholar
PubMed
Introduction Glucagon is a 29-amino acid polypeptide secreted by the α or glucagon cell of the islet of Langerhans in response to hypoglycemia, arginine, gastric inhibitory polypeptide (during ambient reduced glucose levels), gastrin, and potassium
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA
Search for other papers by Thomas H Claus in
Google Scholar
PubMed
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA
Search for other papers by Clark Q Pan in
Google Scholar
PubMed
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA
Search for other papers by Joanne M Buxton in
Google Scholar
PubMed
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA
Search for other papers by Ling Yang in
Google Scholar
PubMed
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA
Search for other papers by Jennifer C Reynolds in
Google Scholar
PubMed
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA
Search for other papers by Nicole Barucci in
Google Scholar
PubMed
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA
Search for other papers by Michael Burns in
Google Scholar
PubMed
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA
Search for other papers by Astrid A Ortiz in
Google Scholar
PubMed
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA
Search for other papers by Steve Roczniak in
Google Scholar
PubMed
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA
Search for other papers by James N Livingston in
Google Scholar
PubMed
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA
Search for other papers by Kevin B Clairmont in
Google Scholar
PubMed
Bayer HealthCare, Biotechnology, 800 Dwight Way, Berkeley, California 94701, USA
Search for other papers by James P Whelan in
Google Scholar
PubMed
Introduction Glucagon-like peptide-1 (GLP-1) is a potent endogenous modulator of insulin secretion that is released by the L-cells in the crypts of the jejunum and ileum in response to a meal ( Kieffer & Habener 1999 ). Its function